The effect of two different anesthesia methods used for cataract surgery on the vascular structure of the optic nerve head

ISRCTN ISRCTN13084070
DOI https://doi.org/10.1186/ISRCTN13084070
Sponsor Sağlık Bilimleri Üniversitesi
Funder Investigator initiated and funded
Submission date
25/06/2026
Registration date
26/06/2026
Last edited
26/06/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Retrobulbar anesthesia and topical anesthesia are both commonly used during cataract surgery. Although retrobulbar anesthesia provides excellent pain control and prevents eye movement during surgery, concerns have been raised about its possible effects on the blood supply of the optic nerve. Optical coherence tomography angiography (OCTA) is a non-invasive imaging technique that can measure the tiny blood vessels around the optic nerve. The aim of this study is to compare changes in optic nerve head blood vessel density after cataract surgery in patients receiving retrobulbar anesthesia or topical anesthesia.

Who can participate?
Adults aged 50 years or older with age-related cataract who are scheduled to undergo routine phacoemulsification cataract surgery and are able to provide written informed consent.

What does the study involve?
Participants are randomly allocated to receive either topical anesthesia or retrobulbar anesthesia before cataract surgery. All participants undergo standard phacoemulsification with implantation of a monofocal intraocular lens. Eye examinations, including best-corrected visual acuity, intraocular pressure measurements, slit-lamp examination, and OCTA imaging, are performed one week before surgery and repeated at one week and one month after surgery.

What are the possible benefits and risks of participating?
Participants may not receive any direct medical benefit from taking part in the study. However, the information gained may improve understanding of the effects of different anesthesia techniques on the optic nerve and help guide future cataract surgery practice. The risks associated with participation are the same as those associated with routine cataract surgery and the anesthesia technique used. OCTA is a non-invasive imaging test and does not expose participants to radiation.

Where is the study run from?
Department of Ophthalmology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Türkiye.

When is the study starting and how long is it expected to run for?
December 2025 to March 2026.

Who is funding the study?
Investigator initiated and funded. The study receives no external funding.

Who is the main contact?
Dr. Alper Can Yılmaz, dralpercnylmz@icloud.com

Contact information

Dr Alper Can Yilmaz
Public, Scientific, Principal investigator

General Tevfik Saglam caddesi, no:1 Etlik/Ankara
Ankara
06010
Türkiye

ORCiD logoORCID ID 0000-0001-7554-0843
Phone +90 554 695 53 73
Email dralpercnylmz@icloud.com

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingBlinded (masking used)
ControlActive
AssignmentParallel
PurposeTreatment
Scientific titleQuantitative assessment of radial peripapillary capillary plexus vessel density after retrobulbar block in cataract surgery
Study objectives 1. To compare changes in radial peripapillary capillary (RPC) plexus vessel density measured by optical coherence tomography angiography (OCTA) between patients receiving retrobulbar anesthesia and those receiving topical anesthesia for phacoemulsification cataract surgery.

2. To evaluate longitudinal changes in RPC plexus vessel density from baseline to postoperative week 1 and month 1 within each anesthesia group.

3. To compare postoperative clinical outcomes, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), surgical duration, cumulative dissipated energy (CDE), and intraoperative and postoperative complications between the two anesthesia groups.
Ethics approval(s)

Approved 23/12/2025, University of Health Sciences Scientific Research Ethics Committee (University of Health Sciences, General Tevfik Saglam Caddesi, No. 1, Ankara, 06010, Türkiye; +90 312 304 61 35; gulhane.baek@sbu.edu.tr), ref: 2025-578

Health condition(s) or problem(s) studiedAssessment of the effects of retrobulbar versus topical anesthesia on optic nerve head microvasculature in patients undergoing phacoemulsification cataract surgery.
InterventionEligible participants are randomly allocated in a 1:1 ratio to receive either topical anesthesia (active comparator) or retrobulbar anesthesia (experimental intervention) before routine phacoemulsification cataract surgery. Randomization is performed using computer-generated random numbers (Microsoft Excel RAND function) by an independent investigator who is not involved in patient examination, image analysis, or statistical evaluation.

Participants allocated to the topical anesthesia group receive topical 0.5% proparacaine hydrochloride ophthalmic drops immediately before surgery. Participants allocated to the retrobulbar anesthesia group receive an ultrasound-guided retrobulbar injection consisting of 4 mL of a local anesthetic mixture containing 40 mg/2 mL lidocaine and 0.025 mg/2 mL epinephrine after negative aspiration to avoid intravascular administration.

All participants undergo standard phacoemulsification cataract surgery with implantation of a single-piece monofocal intraocular lens in the capsular bag. Optical coherence tomography angiography (OCTA) examinations are performed one week before surgery (baseline) and repeated at postoperative week 1 and month 1. Best-corrected visual acuity, intraocular pressure, and slit-lamp examinations are also performed at each scheduled visit. OCTA images are independently reviewed by two masked graders for image quality and segmentation accuracy before quantitative analysis.
Intervention typeProcedure/Surgery
Primary outcome measure(s)
  1. Radial peripapillary capillary (RPC) plexus vessel density measured using optical coherence tomography angiography (OCTA) using the RTVue XR Avanti system (Optovue Inc., Fremont, CA, USA). Vessel density (%) is automatically quantified using the AngioAnalytics™ software at 1 week before surgery, postoperative week 1, and postoperative month 1
Key secondary outcome measure(s)
Completion date07/03/2026

Eligibility

Participant type(s)
Age groupMixed
Lower age limit50 Years
Upper age limit90 Years
SexAll
Target sample size at registration72
Total final enrolment72
Key inclusion criteria1. Adults aged 50 years or older with age-related cataract scheduled for phacoemulsification surgery
2. Presence of visually significant cataract requiring elective cataract surgery
3. Ability to undergo optical coherence tomography angiography (OCTA) with adequate image quality
4. Ability to provide written informed consent
Key exclusion criteria1. Previous intraocular surgery or ocular trauma
2. Corneal disorders affecting OCTA image quality, including corneal ectatic diseases or significant media opacity
3. Retinal vascular disease, age-related macular degeneration, high or degenerative myopia, or any other retinal pathology that could affect OCTA measurements
4. Glaucomatous or non-glaucomatous optic neuropathy
5. Systemic vascular diseases that could influence ocular microvascular measurements
6. Inability to obtain high-quality OCTA images or to complete the scheduled follow-up examinations
Date of first enrolment26/12/2025
Date of final enrolment07/02/2026

Locations

Countries of recruitment

  • Türkiye

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing planDe-identified individual participant data underlying the results reported in this study will be made available upon reasonable request to the corresponding author, dralpercnylmz@icloud.com (Alper Can Yılmaz), subject to institutional policies and ethical approval.

Editorial Notes

26/06/2026: Study’s existence confirmed by the University of Health Sciences Scientific Research Ethics Committee, Turkey.